Yunshuo (Caroline) Tang, MD, PhD recently joined the laboratory of David H. Gutmann, MD, PhD, NF Center Director, to investigate vision loss occurring in the setting of NF1 optic gliomas. Dr. Tang completed her MD and PhD degrees at the University of California, San Francisco, working with Drs. Arturo Alvarez-Buylla, Michael Stryker, and John Rubinstein […]
Month: April 2021
NF Center Trainee Awarded Francis S. Collins Scholar Award
Nicole M. Brossier, MD, PhD was recently awarded a Francis S. Collins Program in Neurofibromatosis Clinical and Translational Research Award. This program is directed by the Neurofibromatosis Therapeutic Acceleration Program at Johns Hopkins University, and is designed to foster the career development of the next generation of leaders in NF. Dr. Brossier is finishing her […]
NF Clinical Trials Consortium Reports Vision Stabilization Following Everolimus Therapy
The NF Clinical Trials Consortium recently published a study examining vision in children with NF1 and optic pathway gliomas (OPGs) following treatment with Everolimus. Leveraging preclinical studies from the Gutmann laboratory demonstrating that mouse Nf1 optic glioma growth is controlled by activated RAS operating through the mechanistic target of rapamycin (mTOR) protein. Everolimus is an […]